Bayview Pharmacy's Testosterone 1.5%/Anastrozole 0.04% Topical Gel is a semisolid formulation dispensed through a pump mechanism. This allows for easy and precise application on the skin, facilitating targeted treatment or absorption of the active ingredients. It is used in the treatment of conditions such as Hypogonadism, Androgen Deficiency, Male Infertility, Breast Cancer, and Prostate Cancer.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present a compounded formulation of Testosterone 1.5% and Anastrozole 0.04% in a topical gel form. This unique formulation is designed to address a range of health conditions, including hypogonadism, androgen deficiency, and breast cancer.
Testosterone is a hormone naturally produced in the body, playing a crucial role in the development of male characteristics. It is commonly used in the treatment of hypogonadism, a condition characterized by the body's insufficient production of testosterone. On the other hand, Anastrozole is an aromatase inhibitor, primarily used in the treatment of breast cancer by inhibiting the production of estrogen.
This compounded formulation combines these two potent ingredients into a semisolid topical gel, dispensed through a pump mechanism. This design allows for easy and precise application on the skin, facilitating targeted treatment and efficient absorption of the active ingredients. The gel-like consistency ensures a comfortable application experience, making it a preferred choice over other forms of administration such as injections or pills.
By applying this topical gel directly to the skin, patients can benefit from a more localized delivery of the active ingredients, potentially enhancing the effectiveness of the treatment. This formulation offers a convenient and non-invasive treatment option for those dealing with hypogonadism and breast cancer.
If you have any queries or require further information about this compounded formulation of Testosterone 1.5%/Anastrozole 0.04% topical gel, or how it can be utilized in the treatment of hypogonadism and breast cancer, please do not hesitate to contact us at Bayview Pharmacy. Our team is committed to assisting you in finding the most suitable treatment option tailored to your individual health needs.
Testosterone 1.5%/Anastrozole 0.04% Topical Gel is a semisolid formulation designed for easy and precise application on the skin. It is primarily used for the treatment of hypogonadism and androgen deficiency in adult males. Additionally, it is indicated for the treatment of breast cancer in postmenopausal women. It is important to note that this formulation has not been studied in pediatric patients and is therefore not recommended for use in this population.
It is crucial to be aware that Testosterone 1.5%/Anastrozole 0.04% Topical Gel may interact with other medications, including oral contraceptives, anticoagulants, and corticosteroids. Therefore, patients should inform their healthcare provider of all medications they are currently taking prior to starting this medication.
Patients using this topical gel should be monitored for signs of hypercalcemia, hypercalciuria, and hypercalciuria-induced nephrolithiasis. Additionally, monitoring for signs of hypertriglyceridemia, hypercholesterolemia, and hyperlipidemia is necessary.
Patients are advised to avoid contact with the eyes, mouth, and other mucous membranes when applying the gel. If contact occurs, the area should be washed with soap and water immediately. Furthermore, patients should use sunscreen and protective clothing when exposed to sunlight to prevent any potential skin reactions.
Activities that may increase the risk of bleeding, such as contact sports, should be avoided while using this medication. Patients are also advised to avoid alcohol consumption during the treatment period.
If you have any questions or concerns about the use of Testosterone 1.5%/Anastrozole 0.04% Topical Gel, please do not hesitate to reach out for further information.
Testosterone 1.5%/Anastrozole 0.04% Topical Gel is a compounded medication designed to address low testosterone levels in men. Testosterone, a hormone naturally produced in the body, is responsible for male characteristics such as facial hair, muscle mass, and sex drive. Anastrozole, on the other hand, is an aromatase inhibitor that works to reduce the amount of estrogen in the body. This combination medication functions by increasing testosterone levels while simultaneously reducing estrogen levels.
The medication is a semisolid formulation dispensed through a pump mechanism, which allows for easy and precise application on the skin. It is designed for targeted treatment or absorption of active ingredients in a gel-like consistency. The gel should be applied directly to clean, dry skin on the upper arms, shoulders, or abdomen, avoiding the genitals or other areas of the body. It is recommended to apply the gel once daily, preferably in the morning, and to wash your hands thoroughly after application to prevent accidental transfer of the medication to other areas of the body.
It's crucial to understand that this medication may take several weeks to start showing effects. Regular blood tests are recommended to monitor your testosterone levels while using this medication. If you have any questions or concerns about using this medication, it is advised to consult with your healthcare provider.
This compounded formulation of Testosterone 1.5%/Anastrozole 0.04% is a semisolid topical gel dispensed through a pump mechanism. This design allows for easy and precise application on the skin, ensuring targeted treatment or absorption of the active ingredients. The gel-like consistency aids in the smooth application and absorption process.
The formulation is versatile and can be used to treat a variety of conditions. It can be used to alleviate menopausal symptoms such as hot flashes, night sweats, and vaginal dryness. The formulation can also be used to manage symptoms of polycystic ovary syndrome (PCOS), including hirsutism, acne, and irregular menstrual cycles.
For transgender individuals experiencing symptoms of hypogonadism, such as low libido, fatigue, and depression, this formulation can be beneficial. Additionally, it can be used to treat symptoms of male infertility, such as low sperm count and motility.
It is crucial to remember that this formulation should only be used under the supervision of a healthcare provider. The dosage and frequency of use should be determined by a healthcare provider, taking into account the individual’s medical history and current health status. If you have any questions about the use of this formulation, please reach out to your healthcare provider or pharmacist.
This is a compounded formulation of Testosterone and Anastrozole, two active ingredients, in a semisolid gel form. It is designed to be applied on the skin for targeted treatment or absorption.
The gel is dispensed through a pump mechanism, which allows for easy and precise application on the skin.
The gel has a semisolid, gel-like consistency that is designed for easy application and absorption through the skin.
You should apply the gel to the skin as directed by your healthcare provider. The pump mechanism allows for easy and precise application.
The active ingredients in this topical gel are Testosterone and Anastrozole.
Testosterone is a hormone that is used in this formulation to treat conditions related to low testosterone levels.
Anastrozole is a medication that is used in this formulation to treat conditions like breast cancer in postmenopausal women. It works by decreasing the amount of estrogen the body makes.
No, this gel is specifically formulated for targeted treatment or absorption of its active ingredients. It should only be used as directed by your healthcare provider.
If you experience any side effects, you should immediately contact your healthcare provider for advice.
You should store the gel at room temperature, away from heat and direct light. Do not freeze. Keep out of the reach of children.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)